CARsgen Therapeutics (02171) Updates Share Repurchase Details and Changes in Issued Shares
Bulletin Express
Jan 23
CARsgen Therapeutics Holdings Limited (02171) disclosed updates on its ordinary shares, including a repurchase on 11 November 2025. The closing balance that day reached 575,086,905 issued shares (excluding treasury shares) and 2,855,500 treasury shares, maintaining a total of 577,942,405 issued shares.
The repurchase on 11 November 2025 involved 245,000 shares at HKD16.5193 per share. A revised disclosure confirmed that the aggregate repurchase price amounted to HKD4,047,240. Shares repurchased on 21 and 23 October 2025 for cancellation, totaling 455,000 shares, remained pending cancellation as of the closing balance date.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.